Condition: General Anesthesia · Sponsor: Haisco-USA Pharmaceuticals, Inc.
To demonstrate HSK3486 0.4/0.2 mg/kg (0.4 mg/kg intravenous \[IV\] slow injection over 30 \[±5\] seconds for the first dose, an additional 0.2 mg/kg if needed) is non-inferior to Propofol 2.0/1.0 mg/kg (2.0 mg/kg IV slow injection over 30 \[±5\] seconds for first dose, an additional 1.0 mg/kg if needed) in success of induction of general anesthesia in adults undergoing elective surgery.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| North Alabama Medical Center | Florence, Alabama, United States | — |
| Helen Keller Hospital | Sheffield, Alabama, United States | — |
| University of Miami Hospital | Miami, Florida, United States | — |
| Gulfcoast Research Institute | Sarasota, Florida, United States | — |
| Phoenix Clinical Research, LLC | Tamarac, Florida, United States | — |
| ForCare Clinical Research | Tampa, Florida, United States | — |
| Atlanta Center for Medical Research | Atlanta, Georgia, United States | — |
| EBGS Clinical Research Center | Snellville, Georgia, United States | — |
| University of Iowa Hospitals and Clinics (Dept of Anesthesia) | Iowa City, Iowa, United States | — |
| U of L Health, University of Louisville Hospital | Louisville, Kentucky, United States | — |
| The Brigham and Women's Hospital | Boston, Massachusetts, United States | — |
| Michigan Medicine | Ann Arbor, Michigan, United States | — |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.